confidence for both domestic and foreign investors. For the principle of the revision, the SEC had already conducted a public hearing during 16 March – 16 April 2018.The revision on the drafted
medical equipment as well as medical service concerning health and esthetics. 2. Overview of operating results in the Year 2017. The overall global economy still has growth direction in fine criteria from
its subsidiaries had total revenue of 929.4 MB, increased from the year 2017 at 92.0 MB by 11.0 percent (by increasing from domestic sales at 15.2 percent and 8.2 percent from export sales) Gross
, increasing by 0.94% from the previous year, which had a total revenue of 167.41 million Baht. This increasing was attributed to higher domestic sales. Moreover, the Company generated higher export volume, but
following results: Revenue Q1/2019, the Company and its subsidiaries had total revenue of 236.7 MB, increased from Q1/2018 in the amount of 23.2 MB, or 10.85 percent. (Domestic sales increased 20.07 percent
domestic sales 24.2% and export sales 75.8%. Gross profit was down from 33.6% to 25.8% due to low margin sale to B2B coupled with the increase in raw material and energy costs. Total expense was Baht 504.6
period in the previous year, which had total revenue of 41.84 million Baht. This increasing was attributed to higher domestic sales. However, the Company recognized lower revenue from overseas sales
revenue of 685 million baht. The reasons are, mainly, as follows; o Improving in domestic market, especially, in traditional trade 219% and also increase in revenue from government contract (G-G) 585% o
aggregator for investors’ portfolios, and (2) Enhance domestic institutional investors’ role to increase Thai equity allocation; Attractive Supply: (1) Attract quality listing to drive new growth into
(Cambodia, Lao PDR, Myanmar, and Vietnam); which are the countries having interesting growth direction of business. The Company also organized the marketing activities to educate the water quality, which is